Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer

被引:39
|
作者
Watanabe, S [1 ]
Asamura, H [1 ]
Suzuki, K [1 ]
Tsuchiya, R [1 ]
机构
[1] Natl Canc Ctr, Div Thorac Surg, Tokyo 1040045, Japan
来源
ANNALS OF THORACIC SURGERY | 2005年 / 79卷 / 05期
关键词
D O I
10.1016/j.athoracsur.2004.11.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Clinical diagnosis of the nodal status is a significant factor in determining the treatment and predicting the prognosis in lung cancer patients. A patient with clinical N1 (cN1) disease is usually considered to be a candidate for surgical intervention in the present staging system in non-small cell lung cancer (NSCLC). However, cN1 disease is a subset for which the method of treatment and surgical results are variable, simply because both upstaging and downstaging can occur. We evaluated the surgical and pathologic results of cN1 NSCLC patients to reveal the problems in diagnosis and surgical management for this subset. Methods. From January 1998 to March 2003, 1,606 patients underwent thoracotomy for primary lung cancer at the National Cancer Center Hospital. Among them, the subjects for this study were 168 (10.5%) NSCLC patients who were clinically diagnosed as having N1 disease and underwent surgery without induction therapy. Results. The tumor cell types of these 168 cN1 NSCLC patients were adenocarcinoma in 73 (44%) and squamous cell carcinoma in 79 (47%). Pneumonectomy was performed in 26% (n = 43) patients, bilobectomy in 15% (n = 25), and exploratory thoracotomy in 11% (n = 19). Of 19 exploratory thoracotomy cases, 10 cases were due to pleural dissemination. The pathologic nodal status of the 135 patients who underwent pulmonary resection and mediastinal dissection was pN0, 19% (n = 25); pN1, 44% (n = 59); and pN2-3, 37% (n = 51). Of the 55 adenocarcinomas, 60% (n = 33) were revealed to be N2 disease on pathologic examination. There were no significant differences in the serum tumor markers between the pN1 and pN2 groups. Among the 25 patients who were down-staged postoperatively (cN1-pN0), 21 patients (84%) showed obstructive pneumonia in the lung. Conclusions. In the staging process of cN1 disease, it will be helpful to perform mediastinoscopy and thoracoscopy to avoid unnecessary thoracotomy especially in adenocarcinoma, even though mediastinal nodes and pleural dissemination were negative on computed tomography investigation. Since extensive pulmonary resection (bilobectomy or pneumonectomy) was required in 41% of the patients, preoperative detailed cardiopulmonary function tests should be mandatory to reduce surgical morbidity and mortality. On the other hand, when pneumonia due to airway obstruction by the tumor exists, false-positive hilar nodes can be expected. (c) 2005 by The Society of Thoracic Surgeons.
引用
收藏
页码:1682 / 1685
页数:4
相关论文
共 50 条
  • [31] Underlying Problems in Surgical Treatment of cT1-2N1 Non-Small Cell Lung Cancer
    Okamoto, Tatsuro
    Tagawa, Tetsuzo
    Morodomi, Yosuke
    Shimamatsu, Shinichiro
    Kitahara, Hirokazu
    Maehara, Yoshihiko
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2017, 65 (02): : 130 - 135
  • [32] Tumor biomarkers in lung cancer: An analysis of patients with pathologically staged N1 non-small cell lung cancer
    Komaki, RU
    Perkins, P
    Fujii, T
    Ro, JY
    Ordenez, NG
    Mountain, C
    [J]. RADIOLOGY, 1996, 201 : 1497 - 1497
  • [33] Predictors for Pathological N1 and N2 Disease in Clinical N1 Non-Small-Cell Lung Cancer
    Fukui, Takayuki
    Okasaka, Toshiki
    Kawaguchi, Koji
    Fukumoto, Koichi
    Nakamura, Shota
    Hakiri, Shuhei
    Ozeki, Naoki
    Yokoi, Kohei
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S589 - S589
  • [34] Risk Factors in Patients with Pathological N1 or N2 Non-Small Cell Lung Cancer
    Tokunaga, Y.
    Okamoto, T.
    Kita, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2075 - S2075
  • [35] Surgical Management of Stage IIIA Non-Small Cell Lung Cancer
    Van Schil, Paul E.
    Berzenji, Lawek
    Yogeswaran, Suresh K.
    Hendriks, Jeroen M.
    Lauwers, Patrick
    [J]. FRONTIERS IN ONCOLOGY, 2017, 7
  • [36] Surgical Management of Non-small Cell Lung Cancer with Mediastinal Lymphadenopathy
    Rocco, G.
    Perrone, F.
    Rossi, A.
    Gridelli, C.
    [J]. CLINICAL ONCOLOGY, 2010, 22 (05) : 325 - 333
  • [37] Outcomes in Thoracic Surgical Management of Non-Small Cell Lung Cancer
    von Ballmoos, Moritz C. Wyler
    Johnstone, David W.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2014, 110 (05) : 539 - 542
  • [38] Surgical Management of Stage IIIA Non-small Cell Lung Cancer
    Toubat, Omar
    Kim, Anthony W.
    [J]. CURRENT PULMONOLOGY REPORTS, 2020, 9 (04) : 151 - 163
  • [39] Surgical Management of Stage IIIA Non-small Cell Lung Cancer
    Omar Toubat
    Anthony W. Kim
    [J]. Current Pulmonology Reports, 2020, 9 : 151 - 163
  • [40] Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer
    Osaki, T
    Nagashima, A
    Yoshimatsu, T
    Tashima, Y
    Yasumoto, K
    [J]. LUNG CANCER, 2004, 43 (02) : 151 - 157